Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Medrxiv : the Preprint Server for Health Sciences|March 17, 2025
KRAS G12D -Specific Targeting with Engineered Exosomes Reprograms the Immune Microenvironment to Enable Efficacy of Immune Checkpoint Therapy in PDAC PatientsValerie S LeBleu, Brandon G Smaglo, Krishnan K Mahadevan, et al.
Nature Communications|September 30, 2025
Engineered exosomes with KrasG12D specific siRNA in pancreatic cancer: a phase I study with immunological correlatesValerie S Kalluri, Brandon G Smaglo, Krishnan K Mahadevan, et al.
Journal for Immunotherapy of Cancer|December 21, 2022
Activated B cells suppress T-cell function through metabolic competitionNobuhiko Imahashi, Rafet Basar, Yuefan Huang, et al.
Blood Advances|December 11, 2019
A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantationLi Li, Han Chen, David Marin, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2020
Generation of glucocorticoid resistant SARS-CoV-2 T-cells for adoptive cell therapyRafet Basar, Nadima Uprety, Emily Ensley, et al.
Nature Medicine|September 29, 2022
KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escapeYe Li, Rafet Basar, Guohui Wang, et al.
Cytotherapy|December 15, 2025
Ex vivo mesenchymal progenitor cell-based cord blood cell expansion and exofucosylation to enhance transplant engraftmentPortia Smallbone, Mayela Mendt, Robert Sackstein, et al.
Cell Reports|July 16, 2021
Generation of glucocorticoid-resistant SARS-CoV-2 T cells for adoptive cell therapyRafet Basar, Nadima Uprety, Emily Ensley, et al.
Pageof 3